Literature DB >> 2167932

High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector.

N Lamarche1, B Massie, M Richer, H Paradis, Y Langelier.   

Abstract

The herpes simplex viruses (HSV-1 and HSV-2) encode a ribonucleotide reductase consisting of two non-identical subunits (RR1 and RR2) which associate to form the active holoenzyme. To facilitate the purification and subsequent biochemical characterization of this enzyme, we have cloned the small subunit 2 of the HSV-2 ribonucleotide reductase (RR2HSV-2) in a helper-independent adenovirus type 5 vector under the control of the adenovirus type 2 major late promoter. After infection of 293 cells with the recombinant virus, the amount of RR2HSV-2 protein produced was eightfold higher than in HSV-2-infected cells. The specific activities of the RR2HSV-2 recombinant subunit and the RR2HSV-2 protein in HSV-2-infected cells were determined by their mixing with saturating amounts of isolated RR1HSV-1 subunit. By comparison of the relative amount of each RR2HSV-2 subunit with its specific activity, we calculated that the recombinant protein intrinsic activity was similar to that of the protein produced in HSV-2-infected cells. These results demonstrated that the adenovirus expression vector is a good system to produce an active RR2HSV-2 subunit in fairly high amounts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167932     DOI: 10.1099/0022-1317-71-8-1785

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Radiation inactivation of ribonucleotide reductase, an enzyme with a stable free radical.

Authors:  G Bolger; M Liuzzi; R Krogsrud; E Scouten; R McCollum; E Welchner; E Kempner
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  New adenovirus vectors for protein production and gene transfer.

Authors:  B Massie; D D Mosser; M Koutroumanis; I Vitté-Mony; L Lamoureux; F Couture; L Paquet; C Guilbault; J Dionne; D Chahla; P Jolicoeur; Y Langelier
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

3.  Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Authors:  B Massie; F Couture; L Lamoureux; D D Mosser; C Guilbault; P Jolicoeur; F Bélanger; Y Langelier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity.

Authors:  N Lamarche; G Matton; B Massie; M Fontecave; M Atta; F Dumas; P Gaudreau; Y Langelier
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

Review 5.  Adenovirus-mediated gene transfer into striated muscles.

Authors:  G Acsadi; B Massie; A Jani
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

6.  Packaging capacity and stability of human adenovirus type 5 vectors.

Authors:  A J Bett; L Prevec; F L Graham
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity.

Authors:  M J E Havenga; L Holterman; I Melis; S Smits; J Kaspers; E Heemskerk; R van der Vlugt; M Koldijk; G J Schouten; G Hateboer; K Brouwer; R Vogels; J Goudsmit
Journal:  Biotechnol Bioeng       Date:  2008-06-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.